BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

174 related articles for article (PubMed ID: 23154746)

  • 1. How much do focal infarcts distort white matter lesions and global cerebral atrophy measures?
    Wang X; Valdés Hernández MC; Doubal F; Chappell FM; Wardlaw JM
    Cerebrovasc Dis; 2012; 34(5-6):336-42. PubMed ID: 23154746
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cerebral small-vessel disease and progression of brain atrophy: the SMART-MR study.
    Kloppenborg RP; Nederkoorn PJ; Grool AM; Vincken KL; Mali WP; Vermeulen M; van der Graaf Y; Geerlings MI;
    Neurology; 2012 Nov; 79(20):2029-36. PubMed ID: 23115210
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Angiotensin-converting enzyme and progression of white matter lesions and brain atrophy--the SMART-MR study.
    Jochemsen HM; Geerlings MI; Grool AM; Vincken KL; Mali WP; van der Graaf Y; Muller M
    J Alzheimers Dis; 2012; 29(1):39-49. PubMed ID: 22214784
    [TBL] [Abstract][Full Text] [Related]  

  • 4. White matter lesions and lacunar infarcts are independently and differently associated with brain atrophy: the SMART-MR study.
    Appelman AP; Vincken KL; van der Graaf Y; Vlek AL; Witkamp TD; Mali WP; Geerlings MI;
    Cerebrovasc Dis; 2010; 29(1):28-35. PubMed ID: 19893309
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Brain atrophy accelerates cognitive decline in cerebral small vessel disease: the LADIS study.
    Jokinen H; Lipsanen J; Schmidt R; Fazekas F; Gouw AA; van der Flier WM; Barkhof F; Madureira S; Verdelho A; Ferro JM; Wallin A; Pantoni L; Inzitari D; Erkinjuntti T;
    Neurology; 2012 May; 78(22):1785-92. PubMed ID: 22592361
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A comparison of location of acute symptomatic vs. 'silent' small vessel lesions.
    Valdés Hernández Mdel C; Maconick LC; Muñoz Maniega S; Wang X; Wiseman S; Armitage PA; Doubal FN; Makin S; Sudlow CL; Dennis MS; Deary IJ; Bastin M; Wardlaw JM
    Int J Stroke; 2015 Oct; 10(7):1044-50. PubMed ID: 26120782
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Close correlation between quantitative and qualitative assessments of white matter lesions.
    Valdés Hernández Mdel C; Morris Z; Dickie DA; Royle NA; Muñoz Maniega S; Aribisala BS; Bastin ME; Deary IJ; Wardlaw JM
    Neuroepidemiology; 2013; 40(1):13-22. PubMed ID: 23075702
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Extent of white matter lesions is related to acute subcortical infarcts and predicts further stroke risk in patients with first ever ischaemic stroke.
    Fu JH; Lu CZ; Hong Z; Dong Q; Luo Y; Wong KS
    J Neurol Neurosurg Psychiatry; 2005 Jun; 76(6):793-6. PubMed ID: 15897500
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Association of white-matter lesions with brain atrophy markers: the three-city Dijon MRI study.
    Godin O; Maillard P; Crivello F; Alpérovitch A; Mazoyer B; Tzourio C; Dufouil C
    Cerebrovasc Dis; 2009; 28(2):177-84. PubMed ID: 19556771
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Brain volumes and cerebrovascular lesions on MRI in patients with atherosclerotic disease. The SMART-MR study.
    Geerlings MI; Appelman AP; Vincken KL; Algra A; Witkamp TD; Mali WP; van der Graaf Y;
    Atherosclerosis; 2010 May; 210(1):130-6. PubMed ID: 19945704
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Counting cavitating lacunes underestimates the burden of lacunar infarction.
    Potter GM; Doubal FN; Jackson CA; Chappell FM; Sudlow CL; Dennis MS; Wardlaw JM
    Stroke; 2010 Feb; 41(2):267-72. PubMed ID: 20044528
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of statins on the progression of cerebral white matter lesion: Post hoc analysis of the ROCAS (Regression of Cerebral Artery Stenosis) study.
    Mok VC; Lam WW; Fan YH; Wong A; Ng PW; Tsoi TH; Yeung V; Wong KS
    J Neurol; 2009 May; 256(5):750-7. PubMed ID: 19252811
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Rationale, design and methodology of the image analysis protocol for studies of patients with cerebral small vessel disease and mild stroke.
    Valdés Hernández Mdel C; Armitage PA; Thrippleton MJ; Chappell F; Sandeman E; Muñoz Maniega S; Shuler K; Wardlaw JM
    Brain Behav; 2015 Dec; 5(12):e00415. PubMed ID: 26807340
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Role of subvoxel free fluid on diffusion parameters in brain tissue with cerebral autosomal dominant arteriopathy with subcortical infarcts and leukoencephalopathy and its correlation with physical disability: histogram analysis of standard and fluid-attenuated MR diffusion.
    Dichgans M; Pütz B; Boos D; Auer DP
    AJNR Am J Neuroradiol; 2003; 24(6):1083-9. PubMed ID: 12812930
    [TBL] [Abstract][Full Text] [Related]  

  • 15. White matter lesion progression in LADIS: frequency, clinical effects, and sample size calculations.
    Schmidt R; Berghold A; Jokinen H; Gouw AA; van der Flier WM; Barkhof F; Scheltens P; Petrovic K; Madureira S; Verdelho A; Ferro JM; Waldemar G; Wallin A; Wahlund LO; Poggesi A; Pantoni L; Inzitari D; Fazekas F; Erkinjuntti T;
    Stroke; 2012 Oct; 43(10):2643-7. PubMed ID: 22879094
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Lacunar infarcts in deep white matter are associated with higher and more fluctuating depressive symptoms during three years follow-up.
    Grool AM; Gerritsen L; Zuithoff NP; Mali WP; van der Graaf Y; Geerlings MI
    Biol Psychiatry; 2013 Jan; 73(2):169-76. PubMed ID: 23079234
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Significance of white matter high intensity lesions as a predictor of stroke from arteriolosclerosis.
    Yamauchi H; Fukuda H; Oyanagi C
    J Neurol Neurosurg Psychiatry; 2002 May; 72(5):576-82. PubMed ID: 11971040
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Association of Ischemic Imaging Phenotype With Progression of Brain Atrophy and Cerebrovascular Lesions on MRI: The SMART-MR Study.
    Rissanen I; Lucci C; Ghaznawi R; Hendrikse J; Kappelle LJ; Geerlings MI;
    Neurology; 2021 Sep; 97(11):e1063-e1074. PubMed ID: 34290128
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Location of cerebrovascular and degenerative changes, depressive symptoms and cognitive functioning in later life: the SMART-Medea study.
    Grool AM; van der Graaf Y; Mali WP; Geerlings MI;
    J Neurol Neurosurg Psychiatry; 2011 Oct; 82(10):1093-100. PubMed ID: 21459931
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Vascular brain lesions, brain atrophy, and cognitive decline. The Second Manifestations of ARTerial disease--Magnetic Resonance (SMART-MR) study.
    Kooistra M; Geerlings MI; van der Graaf Y; Mali WP; Vincken KL; Kappelle LJ; Muller M; Biessels GJ;
    Neurobiol Aging; 2014 Jan; 35(1):35-41. PubMed ID: 23932882
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.